Your browser doesn't support javascript.
loading
Application of interventional therapy on hepatocellular carcinoma with hepatic arterioportal shunts / 中国医师进修杂志
Article in Chinese | WPRIM | ID: wpr-422041
Responsible library: WPRO
ABSTRACT
ObjectiveTo observe the clinical effect of interventional embolization on hepatocellular carcinoma(HCC) with hepatic arterioportal shunts(APS) ,in the hope of improving patients' survival quality and time. MethodsTwenty-nine patients with HCC patients and APS after a successful PVA,steel coils embolization, all patients were given routine TACE therapy. The changes of gastrointestinal bleeding,ascites,diarrhea and aminotransferase were analyzed retrospectively. ResultsNineteen cases got successful embolization in the first time[achievement ratio 65.5%(19/29)]; 3 cases got recurrence after embolization [patency ratio 10.3%(3/29)],7 cases appeared new APS[incidence ratio 24.1%(7/29),5 cases were embolized 2 times, 2 cases were embolized 3 times]. The effective rate of gastrointestinal bleeding,diarrhoea,aacites were 91.7% (11/12), 84.6% ( 11/13 ), 83.3% ( 15/18 ) respectively, which had significant difference between preoperative and postoperative condition. The survival rate of 3 months,6 months, 1 year,and 2 years after operation were 96.6% (28/29),89.7% (26/29),65.5% (19/29),34.5% (10/29). Conclusion Interventional therapy is a safe and effective treatment to HCC with APS.

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Journal of Postgraduates of Medicine Year: 2011 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Journal of Postgraduates of Medicine Year: 2011 Type: Article